Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.

The Bronchiectasis and NTM Association announced today that four abstracts using Bronchiectasis and NTM Research Registry data were presented at the World Bronchiectasis Conference, held July 14-17, ...

Being overweight or obese may lower all-cause mortality risks in non–cystic fibrosis (CF) bronchiectasis patients, while ...

More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially ...

Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis ...

Verona Pharma has seen its stock price jump by 125 percent year-to-date, closing at $104.74 versus $46.44 in the last trading ...

Paediatric-onset bronchiectasis leads to more severe disease than adult-onset, highlighting need for early, tailored care.

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead ...

Bronchiectasis is an abnormal, permanent dilatation of the bronchi and bronchioles caused by repeated cycles of airway infection and inflammation (1). Bronchiectasis is usually divided into non-cystic ...

Bronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...

Background A range of questionnaires have been used to assess health-related quality of life (HRQOL) in bronchiectasis. A systematic review was conducted to evaluate their psychometric properties and ...